Literature DB >> 16340127

NFATc1 directly induces the human beta3 integrin gene in osteoclast differentiation.

T N Crotti1, M Flannery, N C Walsh, J D Fleming, S R Goldring, K P McHugh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16340127      PMCID： PMC1629399     

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN： 1108-7161            Impact factor:   2.041


× No keyword cloud information.
  11 in total

1.  Transduction of TAT fusion proteins into osteoclasts and osteoblasts.

Authors:  Svetlana Dolgilevich; Neeha Zaidi; Jianbo Song; Etsuko Abe; Baljit S Moonga; Li Sun
Journal:  Biochem Biophys Res Commun       Date:  2002-12-06       Impact factor: 3.575

2.  Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator.

Authors:  Norihiro Ishida; Koji Hayashi; Mitsuhiro Hoshijima; Takuya Ogawa; Shintaro Koga; Yuuki Miyatake; Masayoshi Kumegawa; Toru Kimura; Tatsuo Takeya
Journal:  J Biol Chem       Date:  2002-08-08       Impact factor: 5.157

3.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

4.  Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.

Authors:  K P McHugh; K Hodivala-Dilke; M H Zheng; N Namba; J Lam; D Novack; X Feng; F P Ross; R O Hynes; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

5.  Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.

Authors:  M A Horton; M L Taylor; T R Arnett; M H Helfrich
Journal:  Exp Cell Res       Date:  1991-08       Impact factor: 3.905

6.  NF-AT components define a family of transcription factors targeted in T-cell activation.

Authors:  J P Northrop; S N Ho; L Chen; D J Thomas; L A Timmerman; G P Nolan; A Admon; G R Crabtree
Journal:  Nature       Date:  1994-06-09       Impact factor: 49.962

7.  The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells.

Authors:  Hiroaki Hirotani; Nathaniel A Tuohy; Je-Tae Woo; Paula H Stern; Neil A Clipstone
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

8.  Expression of alpha v and beta 3 integrin subunits in rat osteoclasts in situ.

Authors:  D M Shinar; A Schmidt; D Halperin; G A Rodan; M Weinreb
Journal:  J Bone Miner Res       Date:  1993-04       Impact factor: 6.741

9.  Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1.

Authors:  Masahito Matsumoto; Masakazu Kogawa; Seiki Wada; Hiroshi Takayanagi; Masafumi Tsujimoto; Shigehiro Katayama; Koji Hisatake; Yasuhisa Nogi
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

10.  The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor.

Authors:  J Davies; J Warwick; N Totty; R Philp; M Helfrich; M Horton
Journal:  J Cell Biol       Date:  1989-10       Impact factor: 10.539
View more
  4 in total

Review 1.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 2.  The synovio-entheseal complex in enthesoarthritis.

Authors:  Angelo De Cata; Michele Inglese; Rosa Rubino; Francesca Molinaro; Gianluigi Mazzoccoli
Journal:  Clin Exp Med       Date:  2015-02-12       Impact factor: 3.984

3.  Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.

Authors:  Yukiko Komano; Toshihiro Nanki; Kenji Hayashida; Ken Taniguchi; Nobuyuki Miyasaka
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

4.  Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway.

Authors:  Zuocheng Qiu; Ling Li; Yuying Huang; Keda Shi; Lizhong Zhang; Cuishan Huang; Jiechao Liang; Qingqiang Zeng; Jiali Wang; Xiangjiu He; Ling Qin; Xinluan Wang
Journal:  J Orthop Translat       Date:  2022-02-16       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.